scholarly journals Apolipoprotein E gene polymorphisms: a relationship with the risk of coronary artery disease and the effectiveness of lipid-lowering therapy with rosuvastatin

2020 ◽  
Vol 19 (1) ◽  
pp. 17-23
Author(s):  
M. I. Churilin ◽  
S. I. Kononov ◽  
Yu. V. Luneva ◽  
Yu. E. Azarova ◽  
E. Yu. Klesova ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Apolipoprotein E ◽  
Gene Polymorphisms ◽  
Lipid Lowering ◽  
Lipid Lowering Therapy ◽  
E Gene ◽  
Lowering Therapy ◽  
Apolipoprotein E Gene ◽  
Artery Disease

Coronary artery disease

2012 ◽  
Keyword(s):  
Risk Factors ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Antihypertensive Drugs ◽  
Lipid Lowering ◽  
Atherosclerotic Plaques ◽  
Lipid Lowering Therapy ◽  
Lipid Management ◽  
Lowering Therapy ◽  
Artery Disease

Atherosclerosis: pathophysiology 212Development of atherosclerotic plaques 214Epidemiology 216Assessment of atherosclerotic risk 218Risk factors for coronary artery disease 220Hypertension 226Treatment of high blood pressure 228Combining antihypertensive drugs 230Lipid management in atherosclerosis 232Lipid-lowering therapy 236When to treat lipids ...

Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease

2008 ◽  
Vol 9 (10) ◽  
pp. 1475-1486 ◽  
Author(s):  
Tuomo Nieminen ◽  
Mika Kähönen ◽  
Leena E Viiri ◽  
Paula Grönroos ◽  
Terho Lehtimäki
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Apolipoprotein E ◽  
Lipid Lowering ◽  
Lipid Lowering Therapy ◽  
Lipid Levels ◽  
E Gene ◽  
Lowering Therapy ◽  
Apolipoprotein E Gene
Sign in / Sign up

Export Citation Format

Share Document